Please login to the form below
38
Revenue 2017Imbruvica
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Imbruvica was produced by Johnson & Johnson.
EU grants approval for Venclyxto/Gazyvaro combo in CLL
It also has to contend with the combination of AbbVie’s Imbruvica (ibrutinib) plus Gazyvaro, which became the first chemo-free option for first-line CLL therapy last year.
AZ revenues rise, but it says coronavirus could hit 2020
Recently-approved for a new chronic lymphocytic leukaemia (CLL) indication, AZ’s rival to Johnson &Johnson’s blockbuster BTK inhibitor Imbruvica (ibrutinib) – Calquence (acalabrutinib) – also gathered momentum and contributed $56m in
FDA starts priority review of Kite’s CAR-T for mantle cell lymphoma
Other treatment options for advanced MCL include BeiGene’s recently approved BTK inhibitor Brukinsa (zanubrutinib) and AbbVie/Johnson &Johnson’s established BTK inhibitor Imbruvica (ibrutinib).
Skyrizi, Rinvoq help AbbVie weather Humira slowdown
Outside its critical immunology franchise there were also gains for blood cancer therapy Imbruvica (ibrutinib), up almost 29% to $1.3bn, as well as a $251m contribution from newer therapy Venclexta
EMA begins review of Kite’s CAR-T for mantle cell lymphoma
Current treatment options for MCL include AstraZeneca’s BTK inhibitor Calquence (acalabrutinib) and Johnson &Johnson/AbbVie’s BTK inhibitor Imbruvica (ibrutinib).
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Regeneron says antibody for COVID-19 could be ready this year
- Amgen adds Otezla to the COVID-19 candidate list
- UK clears NHS use of Gilead’s remdesivir for COVID-19 patients
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- NICE approves Roche’s Tecentriq in TNBC after revising deal
- CEPI-backed coronavirus vaccine from Novavax starts trials
- IFPMA industry association conference: ‘no-one left behind’ on coronavirus vaccine
- Roche/Gilead tag team fights COVID-19 with Actemra/remdesivir
- GSK plans to produces one billion doses of vaccine adjuvant for COVID-19
- The big issue
- The field team are off the road! What should they do next?
- INFOGRAPHIC 02: The Importance of clinical study websites
PMHub
Creative Medical Research
Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...
Latest intelligence
- The big issue
- Whether you want to lead or follow, you need to understand the elephant in the C-suite...
- INFOGRAPHIC 02: The Importance of clinical study websites
- Here’s a infographic of why clinical study websites are important to patient recruitment and retention strategies…...
- Working with, Advocating for, and Empowering Patients
- A holistic view of how to work with patients virtually...
Quick links
Infographics
